Predisposition to prolonged neutropenia after chemotherapy for paediatric acute myeloid leukaemia is associated with better prognosis in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study

被引:4
|
作者
Aoki, Takahiro [1 ]
Takahashi, Hiroyuki [2 ]
Tanaka, Shiro [3 ]
Shiba, Norio [4 ]
Hasegawa, Daiichiro [5 ]
Iwamoto, Shotaro [6 ]
Terui, Kiminori [7 ]
Moritake, Hiroshi [8 ]
Nakayama, Hideki [9 ]
Shimada, Akira [10 ]
Koh, Katsuyoshi [11 ]
Goto, Hiroaki [12 ]
Kosaka, Yoshiyuki [5 ]
Saito, Akiko M. [13 ]
Horibe, Keizo [13 ]
Kinoshita, Akitoshi [14 ]
Tawa, Akio [15 ]
Taga, Takashi [16 ]
Adachi, Souichi [17 ]
Tomizawa, Daisuke [18 ]
机构
[1] Chiba Univ, Grad Sch Med, Dept Pediat, Chiba, Japan
[2] Toho Univ, Dept Pediat, Tokyo, Japan
[3] Kyoto Univ, Grad Sch Med, Dept Clin Biostat, Clin Biostat Course, Kyoto, Japan
[4] Yokohama City Univ Med, Grad Sch Med, Dept Pediat, Yokohama, Kanagawa, Japan
[5] Hyogo Prefectural Kobe Childrens Hosp, Dept Hematol Oncol, Kobe, Hyogo, Japan
[6] Mie Univ, Dept Pediat, Tsu, Mie, Japan
[7] Hirosaki Univ, Dept Pediat, Hirosaki, Aomori, Japan
[8] Univ Miyazaki, Fac Med, Div Pediat, Miyazaki, Japan
[9] Natl Hosp Org, Dept Pediat, Kyushu Canc Ctr, Fukuoka, Japan
[10] Okayama Univ Hosp, Dept Pediat Hematol Oncol, Okayama, Japan
[11] Saitama Childrens Med Ctr, Dept Hematol Oncol, Saitama, Japan
[12] Kanagawa Childrens Med Ctr, Div Hematol Oncol, Yokohama, Kanagawa, Japan
[13] Natl Hosp Org, Clin Res Ctr, Nagoya Med Ctr, Nagoya, Aichi, Japan
[14] St Marianna Univ, Sch Med, Dept Pediat, Kawasaki, Kanagawa, Japan
[15] Higashiosaka Aramoto Heiwa Clin, Higashiosaka, Osaka, Japan
[16] Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga, Japan
[17] Kyoto Univ, Dept Human Hlth Sci, Kyoto, Japan
[18] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Div Leukemia & Lymphoma, Tokyo, Japan
关键词
acute myeloid leukaemia; chemosensitivity; children; myelosuppression; neutropenia; LYMPHOBLASTIC-LEUKEMIA; CHILDREN; RELAPSE; THERAPY;
D O I
10.1111/bjh.16656
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The variability in myelosuppression after chemotherapy for acute myeloid leukaemia (AML) can affect its prognosis; however, the underlying mechanism remains controversial. In the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study, we showed that prolonged neutropenia was associated with high overall survival (P = 0 center dot 011) and low frequency of relapse (P = 0 center dot 042) in patients without granulocyte-colony stimulating factor (G-CSF) who completed the indicated treatment protocol. Our data indicate that predisposition to prolonged neutropenia after chemotherapy is correlated with a better outcome of AML treatment. Our results promote the usage of individualised drug dosing strategies to improve the therapeutic outcome in AML patients.
引用
收藏
页码:176 / 180
页数:5
相关论文
共 50 条
  • [41] High-dose methotrexate pharmacokinetics and its impact on prognosis of paediatric acute lymphoblastic leukaemia patients: A population pharmacokinetic study
    Chen, Xiaoxiao
    Li, Jing
    Yu, Liting
    Hu, Wenting
    Cai, Jiaoyang
    Wang, Zhuo
    Chen, Changcheng
    Zhang, Xin
    Xie, Yangyang
    Wu, Kefei
    Mo, Yixiao
    Chen, Jihui
    Shen, Shuhong
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1354 - 1366
  • [42] Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukaemia: results of the United Kingdom Medical Research Council's 10th AML Trial
    Stevens, RF
    Hann, IM
    Wheatley, K
    Gray, RG
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 (01) : 130 - 140
  • [43] Differences in infection prophylaxis measures between paediatric acute myeloid leukaemia study groups within the international Berlin-Frankfurt-Munster (I-BFM) study group
    Klein, Kim
    Hasle, Henrik
    Abrahamsson, Jonas
    De Moerloose, Barbara
    Kaspers, Gertjan J. L.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (01) : 87 - 95
  • [44] Negative CD19 Expression Is Associated with Inferior Relapse-Free Survival in RUNX1-RUNX1T1-Positive Acute Myeloid Leukemia; The Japanese Pediatric Leukemia/Lymphoma Study Group Experience from the AML-05 Study
    Imamura, Toshihiko
    Sakamoto, Kenichi
    Shiba, Norio
    Deguchi, Takao
    Kiyokawa, Nobutaka
    Hashii, Yoshiko
    Saito, Akiko
    Tomizawa, Daisuke
    Taga, Takashi
    Adachi, Souichi
    BLOOD, 2018, 132
  • [45] PROLONGED THROMBOCYTOPENIA IN ACUTE MYELOID LEUKAEMIA (AML) PATIENTS TREATED WITH FRACTIONATED DOSES OF GEMTUZUMAB OZOGAMICIN (GO) IN THE ALFA-0701 STUDY DOES NOT CONFER AN ADVERSE PROGNOSIS
    Pautas, C.
    De Gunzburg, N.
    Raffoux, E.
    Rigaudeau, S.
    Gardin, C.
    Berthon, C.
    Turlure, P.
    Marie, J.
    Michallet, M.
    Janvier, M.
    Caillot, D.
    Suarez, F.
    Tilly, H.
    Reman, O.
    Rousselot, P.
    Dombret, H.
    Chevret, S.
    Castaigne, S.
    HAEMATOLOGICA, 2012, 97 : 24 - 24
  • [46] Results of immunosuppressive therapy in children with acquired severe aplastic anaemia (SAA). Report Polish Paediatric Leukaemia and Lymphoma Study Group.
    Pawelec, K
    Matysiak, M
    Niewiadomska, E
    Rokicka-Milewska, R
    Jackowska, T
    Kowalczyk, J
    Stefaniak, J
    Balwierz, W
    Zalecka-Czerpko, E
    Chybicka, A
    Szmyd, K
    Sonta-Jakimczyk, D
    Bubala, H
    Krauze, A
    Wysocki, M
    Kurylak, A
    Wachowiak, J
    Kaczmarek-Karnold, M
    Stolarska, M
    Karolczyk, I
    Krawczuk-Rybak, M
    Leszczynska, E
    Urasinski, T
    Peregud-Pogorzelski, J
    Wlazlowski, M
    Balcerska, A
    BLOOD, 2005, 106 (11) : 16B - 16B
  • [47] Infectious complications in paediatric acute myeloid leukaemia:: low incidence of bacteraemia due to viridans streptococci in a 10-year retrospective study
    Brunet, AS
    Ploton
    Galambrun, C
    Pondarre, C
    Pages, MP
    Bleyzac, N
    Freydière, AM
    Barbé, G
    Bertrand, Y
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S102 - S103
  • [48] Biomarkers to predict infection and infection-related complications during chemotherapy-induced neutropenia in acute myeloid leukaemia: a pilot study
    van deGeer, Annemarie
    Zandstra, Judith
    Tanck, Michael W. T.
    Nur, Efran
    vanMierlo, Gerard
    Jongerius, Ilse
    vanBruggen, Robin
    Zeerleder, Sacha S.
    Kuijpers, Taco W.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (05) : 1008 - 1012
  • [49] Clinical and molecular characteristics of paediatric mature B-cell acute lymphocytic leukaemia and non-Hodgkin lymphoma with bone marrow involvement: A joint study between the CCCG leukaemia and lymphoma groups
    Zhao, Jie
    Liu, Tian-Feng
    Wu, Ke-fei
    Yang, Liang-Chun
    Xu, Xue-Ju
    Lu, Jun
    Shao, Jing-Bo
    Li, Fu
    Ma, Fu-Tian
    Guo, Xia
    Li, Hui
    Liu, Ai-Guo
    Wang, Ning-Ling
    Shen, He-Ping
    Li, Yang
    Liu, Si-Xi
    Liang, Chang-Da
    Shen, Shu-Hong
    Fang, Yong-Jun
    Gao, Yi-Jin
    BRITISH JOURNAL OF HAEMATOLOGY, 2025,
  • [50] Effects of Mylotarg™ (Gemtuzumab ozogomycin, GO) in combination with standard induction chemotherapy in the treatment of acute myeloid leukaemia (AML):: A feasibility study.
    Kell, JW
    Burnett, AK
    Chopra, R
    Yin, J
    BLOOD, 2001, 98 (11) : 123A - 124A